Target intelligence / Profile preview

ADORA1 antisense RNA 2 (ADORA1-AS2)

Target
ADORA1-AS2
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA, Non-protein coding
01

Overview

ADORA1 antisense RNA 2 (ADORA1-AS2) does not appear in main biomedical databases as a well-characterized or established molecular target. There is strong evidence that the name refers to a predicted or annotated non-coding RNA transcript, specifically an antisense long non-coding RNA (lncRNA) transcribed from the opposite strand of the ADORA1 (Adenosine A1 receptor) gene locus. The gene ADORA1 is a well-characterized G protein-coupled receptor involved in neurotransmission and immunomodulation. "ADORA1 antisense RNA 2" refers to an antisense non-coding RNA overlapping or nearby the ADORA1 locus. There is no robust evidence that it encodes a protein or acts as a canonical drug target such as a receptor, enzyme, or transporter. Most mentions of antisense transcripts like this refer to NR_ or XR_ sequence predictions in genome annotations and are not validated as functional therapeutic targets nor as having known interacting drugs. No actionable drugs, biomarkers, or mechanism of action are described for "ADORA1-AS2" in the literature. Most therapeutic or biomarker research focuses on the protein ADORA1, not the antisense RNA. ADORA1 antisense RNA 2 (ADORA1-AS2) is an annotated long non-coding RNA (lncRNA) transcript that is transcribed from the antisense strand relative to the ADORA1 gene locus. There is no strong evidence of an established biological function, protein product, or direct role in disease for ADORA1-AS2. It is not considered a canonical therapeutic target. Research in the ADORA1 genomic region primarily centers on the protein-coding ADORA1 gene, a major adenosine receptor; antisense non-coding RNAs like ADORA1-AS2 are annotated in genome projects but have not been experimentally characterized as druggable targets or biomarkers. In summary, ADORA1-AS2 is not a canonical therapeutic target. The entity is correctly named but not considered a target. Information is lacking regarding biological role, clinical utility, and druggability. Focus therapeutic and druggability queries on the ADORA1 protein rather than the antisense RNA.

Other names
ADORA1-AS2ADORA1 antisense RNA 2
02

Mechanism of action

None described

03

Biological functions

Unknown (No well-defined biological function for ADORA1-AS2. Antisense RNAs can potentially regulate expression of the sense transcript, e.g., ADORA1 mRNA, but no such function is experimentally validated for this transcript.)
04

Disease associations

Unknown (No direct disease association established. Some antisense lncRNAs regulate disease-relevant loci but ADORA1-AS2 is not directly linked to disease.)
05

Safety considerations

None described
06

Interacting drugs

None described
07

Biomarkers

None described

Beyond the preview

Go deeper on ADORA1 antisense RNA 2 (ADORA1-AS2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ADORA1 antisense RNA 2 (ADORA1-AS2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call